Home › Non-Small Cell Lung Cancer › California › Torrance
Non-Small Cell Lung Cancer clinical trials in Torrance, CA
11 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Torrance (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
RecruitingPhase 3
- Torrance Memorial Physician Network - Cancer Care, Torrance
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Torrance Memorial Physician Network - Cancer Care, Torrance
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Cancer and Blood Specialty Clinic, Torrance
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RecruitingObservational study
- Torrance Memorial Physician Network-Cancer Care, Torrance
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RecruitingPhase 3
- Clinical Study Site, Torrance
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
RecruitingPhase 1
- Cedars-Sinai Cancer at Hunt Cancer Center - TMPNCC, Torrance
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Cancer AND Blood Specialty Clinic, Torrance
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Torrance Memorial Physician Network - Cancer Care, Torrance
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- City of Hope South Bay, Torrance
- Torrance Memorial Physician Network - Cancer Care, Torrance
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Torrance Memorial Physician Network - Cancer Care, Torrance
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
RecruitingPhase 2
- City of Hope South Bay, Torrance
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Torrance
- Breast Cancer9 studies
- Overweight9 studies
- Obesity9 studies
- Lung Cancer7 studies
- Cardiovascular Disease7 studies
- Bladder Cancer7 studies
- Schizophrenia6 studies
- Heart Failure5 studies
- Atherosclerosis5 studies
- Metastatic Cancer4 studies
- Colorectal Cancer4 studies
- Coronary Artery Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.